Patent · US Active

Method for diagnosing neurodegenerative diseases

US9863950B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 19, 2015
Grant dateJan 9, 2018
Priority date
Expiry dateMay 19, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/2835
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention relates to a method for diagnosing, in vitro, a neurodegenerative disease in an individual, in which: the level of the double-stranded RNA-dependent protein kinase (PKR) in a sample of cerebrospinal fluid from the individual is determined; it is deduced therefrom whether the individual is suffering from a neurodegenerative disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.